Katya Tsaioun

Research output

Research output per year 1997 2022 2023

• 27 Article
• 10 Review article
• 3 Comment/debate
• 2 Chapter
• 3 More
  • 1 Book
  • 1 Foreword/postscript
  • 1 Letter

Research output per year

Research output per year

Search results

• 2023

  First Organoid Intelligence (OI) workshop to form an OI community

  Morales Pantoja, I. E., Smirnova, L., Muotri, A. R., Wahlin, K. J., Kahn, J., Boyd, J. L., Gracias, D. H., Harris, T. D., Cohen-Karni, T., Caffo, B. S., Szalay, A. S., Fang, H., Zack, D. J., Etienne-Cummings, R., Akwaboah, A., Romero Sandoval, J. C., Alam El Din, D. M., Plotkin, J. D., Paulhamus, B. L., Johnson, E. C., & 22 othersGilbert, F., Curley, J. L., Cappiello, B., Schwamborn, J. C., Hill, E. J., Roach, P., Tornero, D., Krall, C., Parri, R., Sillé, F., Levchenko, A., Jabbour, R. E., Kagan, B. J., Berlinicke, C. A., Huang, Q., Maertens, A., Herrmann, K., Tsaioun, K., Dastgheyb, R., Habela, C. W., Vogelstein, J. T. & Hartung, T., 2023, In: Frontiers in Artificial Intelligence. 6, 1116870.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Brain 100%
  • Stem cells 48%
  • Drug Development 24%
  • Bioengineering 23%
  • Monolayers 22%

• Guidance on protocol development for EFSA generic scientific assessments

  EFSA Scientific Committee (SC), Oct 2023, In: EFSA Journal. 21, 10, e08312.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Research Design 100%
  • protocols 90%
  • Bibliographic Databases 86%
  • Statistical Models 70%
  • Literature 67%
• 2022

  A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear tetrapeptides

  Tanwar, S., Auberger, P., Gillet, G., DiPaola, M., Tsaioun, K. & Villoutreix, B. O., Jun 2022, In: Data in Brief. 42, 108159.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Datasets 67%
  • Databases 51%
  • Drug Discovery 43%
  • Peptides 40%
  • Names 40%

• Application of Evidence-Based Methods to Construct Mechanism-Driven Chemical Assessment Frameworks

  Hoffmann, S., Aiassa, E., Angrish, M., Beausoleil, C., Bois, F. Y., Ciccolallo, L., Craig, P. S., de Vries, R. B. M., Dorne, J. L. C. M., Druwe, I. L., Edwards, S. W., Eskes, C., Georgiadis, M., Hartung, T., Kienzler, A., Kristjansson, E. A., Lam, J., Martino, L., Meek, B., Morgan, R. L., & 19 othersMunoz-Guajardo, I., Noyes, P. D., Parmelli, E., Piersma, A., Rooney, A., Sena, E., Sullivan, K., Tarazona, J., Terron, A., Thayer, K., Turner, J., Verbeek, J., Verloo, D., Vinken, M., Watford, S., Whaley, P., Wikoff, D., Willett, K. & Tsaioun, K., 2022, In: ALTEX. 39, 3, p. 499-518 20 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Adverse Outcome Pathways 100%
  • Risk Assessment 50%
  • Education 37%
  • Food Safety 37%
  • Systematic Reviews 22%

• Biological plausibility in environmental health systematic reviews: a GRADE concept paper

  Whaley, P., Piggott, T., Morgan, R. L., Hoffmann, S., Tsaioun, K., Schwingshackl, L., Ansari, M. T., Thayer, K. A. & Schünemann, H. J., Apr 2022, In: Environment international. 162, 107109.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • environmental health 100%
  • recommendation 69%
  • exposure 21%
  • public health 16%
  • animal 12%

• Biological plausibility in environmental health systematic reviews: a GRADE concept paper

  Whaley, P., Piggott, T., Morgan, R. L., Hoffmann, S., Tsaioun, K., Schwingshackl, L., Ansari, M. T., Thayer, K. A. & Schünemann, H. J., Jun 2022, In: Journal of Clinical Epidemiology. 146, p. 32-46 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Environmental Health 100%
  • Systematic Reviews 60%
  • Research Personnel 18%
  • Health Services Needs and Demand 15%
  • Theoretical Models 11%

• COVID-19 through Adverse Outcome Pathways: Building Networks to Better Understand the Disease - 3rd CIAO AOP Design Workshop

  Clerbaux, L. A., Amigó, N., Amorim, M. J., Bal-Price, A., Leite, S. B., Beronius, A., Bezemer, G. F. G., Bostroem, A. C., Carusi, A., Coecke, S., Concha, R., Daskalopoulos, E. P., Debernardi, F., Edrosa, E., Edwards, S. W., Filipovska, J., Garcia-Reyero, N., Gavins, F. N. E., Halappanavar, S., Hargreaves, A. J., & 38 othersHogberg, H. T., Huynh, M. T., Jacobson, D., Josephs- Spaulding, J., Kim, Y. J., Kong, H. J., Krebs, C. E., Lam, A., Landesmann, B., Layton, A. R., Lee, Y. O., Macmillan, D. S., Mantovani, A., Margiotta-Casaluci, L., Martens, M., Masereeuw, R., Mayasich, S. A., Mei, L. M., Mortensen, H., Munoz, A., Nymark, P., Ohayon, E., Ojasi, J. M., Paini, A., Parissis, N., Parvatam, S., Pistollato, F., Sachana, M., Sørli, J. B., Sullivan, K. M., Sund, J., Tanabe, S., Tsaioun, K., Vinken, M., Viviani, L., Waspe, J., Willett, C. & Wittwehr, C., 2022, In: ALTEX. 39, 2, p. 322-335 14 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Adverse Outcome Pathways 100%
  • Education 37%
  • Crowdsourcing 32%
  • Disease Progression 32%
  • SARS Virus 29%

• Deploying elements of scoping review methods for adverse outcome pathway development: a space travel case example

  Kozbenko, T., Adam, N., Lai, V., Sandhu, S., Kuan, J., Flores, D., Appleby, M., Parker, H., Hocking, R., Tsaioun, K., Yauk, C., Wilkins, R. & Chauhan, V., 2022, In: International journal of radiation biology. 98, 12, p. 1777-1788 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Adverse Outcome Pathways 100%
  • Space Flight 77%
  • Workflow 44%
  • Decision Making 11%
  • Software 10%

• Development of an Evidence-Based Risk Assessment Framework

  Krewski, D., Saunders-Hastings, P., Baan, R. A., Barton-Maclaren, T. S., Browne, P., Chiu, W. A., Gwinn, M., Hartung, T., Kraft, A. D., Lam, J., Lewis, R. J., Sanaa, M., Morgan, R. L., Paoli, G., Rhomberg, L., Rooney, A., Sand, S., Schünemann, H. J., Straif, K., Thayer, K. A., & 1 othersTsaioun, K., 2022, In: ALTEX. 39, 4, p. 667-693 27 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Risk Assessment 100%
  • Consensus Development Conferences 37%
  • Private Sector 29%
  • North America 25%
  • Health 23%

• How Evidence-Based Methodologies Can Help Identify and Reduce Uncertainty in Chemical Risk Assessment

  Hoffmann, S., Whaley, P. & Tsaioun, K., 2022, In: ALTEX. 39, 2, p. 175-182 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Uncertainty 100%
  • Risk Assessment 90%
  • Environmental Health 16%
  • Health Services Research 15%
  • Occupational Health 14%

• Kinase signaling as a drug target modality for regulation of vascular hyperpermeability: A case for ARDS therapy development

  Kayyali, U. S., Ghandakly, E., Singh, N., Villoutreix, B. O. & Tsaioun, K., May 2022, In: Drug Discovery Today. 27, 5, p. 1448-1456 9 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Adult Respiratory Distress Syndrome 95%
  • Permeability 69%
  • Phosphotransferases 67%
  • Blood Vessels 51%
  • Pharmaceutical Preparations 36%

• Pluripotent stem cell assays: Modalities and applications for predictive developmental toxicity

  Piersma, A. H., Baker, N. C., Daston, G. P., Flick, B., Fujiwara, M., Knudsen, T. B., Spielmann, H., Suzuki, N., Tsaioun, K. & Kojima, H., Jan 2022, In: Current Research in Toxicology. 3, 100074.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Colony-Forming Units Assay 100%
  • Developmental 83%
  • Pluripotent Stem Cells 80%
  • Embryonic Stem Cells 36%
  • Toxicology 33%

• Probabilistic Risk Assessment - The Keystone for the Future of Toxicology

  Maertens, A., Golden, E., Luechtefeld, T. H., Hoffmann, S., Tsaioun, K. & Hartung, T., 2022, In: ALTEX. 39, 1, p. 3-29 27 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Toxicology 100%
  • Uncertainty 94%
  • Risk Assessment 85%
  • Adverse Outcome Pathways 24%
  • Bayes Theorem 17%

• Systematic Review in Evidence-Based Risk Assessment

  Farhat, N., Tsaioun, K., Saunders-Hastings, P., Morgan, R. L., Ramoju, S., Hartung, T. & Krewski, D., 2022, In: ALTEX. 39, 3, p. 463-479 17 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Risk Assessment 100%
  • Systematic Reviews 88%
  • Ecotoxicology 24%
  • Clinical Studies 20%
  • Environmental Health 18%

• The effect of radiofrequency electromagnetic fields (RF-EMF) on biomarkers of oxidative stress in vivo and in vitro: A protocol for a systematic review

  Henschenmacher, B., Bitsch, A., de las Heras Gala, T., Forman, H. J., Fragoulis, A., Ghezzi, P., Kellner, R., Koch, W., Kuhne, J., Sachno, D., Schmid, G., Tsaioun, K., Verbeek, J. & Wright, R., Jan 2022, In: Environment international. 158, 106932.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • oxidative stress 100%
  • biomarker 81%
  • protocol 70%
  • exposure 39%
  • World Health Organization 38%
• 2021

  Applying evidence-based methods to the development and use of adverse outcome pathways

  de Vries, R. B. M., Angrish, M., Browne, P., Brozek, J., Rooney, A. A., Wikoff, D. S., Whaley, P., Edwards, S. W., Morgan, R. L., Druwe, I. L., Hoffmann, S., Hartung, T., Thayer, K., Avey, M. T., Beverly, B. E. J., Falavigna, M., Gibbons, C., Goyak, K., Kraft, A., Nampo, F., & 7 othersQaseem, A., Sears, M., Singh, J. A., Willett, C., Yost, E. Y., Schünemann, H. & Tsaioun, K., Apr 20 2021, In: ALTEX. 38, 2, p. 336-347 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Adverse Outcome Pathways 100%
  • Education 18%
  • Systematic Reviews 14%
  • Toxicity Tests 13%
  • Automation 12%

• A Systematic Review to Compare Chemical Hazard Predictions of the Zebrafish Embryotoxicity Test with Mammalian Prenatal Developmental Toxicity

  Hoffmann, S., Marigliani, B., Akgün-Ölmez, S. G., Ireland, D., Cruz, R., Busquet, F., Flick, B., Lalu, M., Ghandakly, E. C., De Vries, R. B. M., Witters, H., Wright, R. A., Ölmez, M., Willett, C., Hartung, T., Stephens, M. L. & Tsaioun, K., Sep 1 2021, In: Toxicological Sciences. 183, 1, p. 14-35 22 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Embryotoxicity 100%
  • Developmental 72%
  • Zebrafish 60%
  • Systematic Reviews 43%
  • Toxicology 34%

• GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making

  GRADE Working Group, Jan 2021, In: Journal of Clinical Epidemiology. 129, p. 138-150 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Decision Making 100%
  • Terminology 81%
  • Guidelines 78%
  • Delivery of Health Care 73%
  • Health 59%
  3 Scopus citations

• Improving the Quality of Toxicology and Environmental Health Systematic Reviews: What Journal Editors Can Do

  Whaley, P., Blaauboer, B. J., Brozek, J., Cohen Hubal, E. A., Hair, K., Kacew, S., Knudsen, T. B., Kwiatkowski, C. F., Mellor, D. T., Olshan, A. F., Page, M. J., Rooney, A. A., Radke, E. G., Shamseer, L., Tsaioun, K., Tugwell, P., Wikoff, D. & Woodruff, T. J., 2021, In: ALTEX. 38, 3, p. 513-522 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Environmental Health 100%
  • Toxicology 79%
  • Systematic Reviews 60%
  • Manuscripts 18%
  • Workflow 17%

• Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review

  Dirven, H., Vist, G. E., Bandhakavi, S., Mehta, J., Fitch, S. E., Pound, P., Ram, R., Kincaid, B., Leenaars, C. H. C., Chen, M., Wright, R. A. & Tsaioun, K., Dec 2021, In: Scientific reports. 11, 1, 6403.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Troglitazone 100%
  • Chemical and Drug Induced Liver Injury 91%
  • Rosiglitazone 89%
  • Systematic Reviews 51%
  • Pharmaceutical Preparations 24%

• Reviewing the animal literature: how to describe and choose between different types of literature reviews

  Leenaars, C., Tsaioun, K., Stafleu, F., Rooney, K., Meijboom, F., Ritskes-Hoitinga, M. & Bleich, A., Apr 2021, In: Laboratory Animals. 55, 2, p. 129-141 13 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • terminology 100%
  • Terminology 84%
  • Animals 83%
  • animals 70%
  • animal research 55%
  2 Scopus citations
• 2020

  EFSA - Johns hopkins food safety symposium 2019

  Libowitz, L., Bloem, M. W., Hugas, M., Tsaioun, K., Url, B. & Hartung, T., Mar 2020, In: ALTEX. 37, 2, p. 312-314 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges

  Geerts, H., Wikswo, J., van der Graaf, P. H., Bai, J. P. F., Gaiteri, C., Bennett, D., Swalley, S. E., Schuck, E., Kaddurah-Daouk, R., Tsaioun, K. & Pelleymounter, M., Jan 1 2020, In: CPT: Pharmacometrics and Systems Pharmacology. 9, 1, p. 5-20 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug Discovery 100%
  • Pharmacology 93%
  • Drug Development 88%
  • Neuroscience 80%
  • Neurology 73%
  11 Scopus citations
• 2019

  Adaptation of the Systematic Review Framework to the Assessment of Toxicological Test Methods: Challenges and Lessons Learned with the Zebrafish Embryotoxicity Test

  Stephens, M. L., Akgün-Ölmez, S. G., Hoffmann, S., De Vries, R., Flick, B., Hartung, T., Lalu, M., Maertens, A., Witters, H., Wright, R. & Tsaioun, K., Sep 1 2019, In: Toxicological Sciences. 171, 1, p. 56-68 13 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Embryotoxicity 100%
  • Developmental 72%
  • Zebrafish 60%
  • Toxicology 57%
  • Systematic Reviews 43%
  1 Scopus citations

• Software tools for literature screening in systematic reviews in biomedical research

  van der Mierden, S., Tsaioun, K., Bleich, A. & Leenaars, C. H. C., 2019, In: ALTEX. 36, 3, p. 508-517 10 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Biomedical Research 100%
  • Software 75%
  • Systematic Reviews 73%
  • Animals 19%
  • Research Personnel 13%
  10 Scopus citations

• Toward good in vitro reporting standards

  Hartung, T., de Vries, R., Hoffmann, S., Hogberg, H. T., Smirnova, L., Tsaioun, K., Whaley, P. & Leist, M., 2019, In: ALTEX. 36, 1, p. 3-17 15 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Data Display 100%
  • Big Data 93%
  • Artificial Intelligence 91%
  • In Vitro Techniques 90%
  • Social Justice 86%
  16 Scopus citations
• 2018

  Better science for safer medicines: the human imperative

  Archibald, K., Tsaioun, K., Kenna, J. G. & Pound, P., Dec 1 2018, In: Journal of the Royal Society of Medicine. 111, 12, p. 433-438 6 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access
  8 Scopus citations
• 2017

  A primer on systematic reviews in toxicology

  Hoffmann, S., de Vries, R. B. M., Stephens, M. L., Beck, N. B., Dirven, H. A. A. M., Fowle, J. R., Goodman, J. E., Hartung, T., Kimber, I., Lalu, M. M., Thayer, K., Whaley, P., Wikoff, D. & Tsaioun, K., Jul 1 2017, In: Archives of Toxicology. 91, 7, p. 2551-2575 25 p.

  Research output: Contribution to journal › Review article › peer-review

  • Toxicology 100%
  • Systematic Reviews 75%
  • Fuel 42%
  • Application 32%
  33 Scopus citations
• 2016

  ADME Properties Leading to Toxicity

  Tsaioun, K., Jan 1 2016, Drug Discovery Toxicology: From Target Assessment to Translational Biomarkers. wiley, p. 82-92 11 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Pharmacokinetics 100%
  • Drug 87%
  • Pharmaceutical Preparations 68%
  • Clinical Trials 43%
  • Pharmacological Metabolism 36%

• Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods

  Tsaioun, K., Blaauboer, B. J. & Hartung, T., 2016, In: ALTEX. 33, 4, p. 343-358 16 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug Industry 100%
  • Toxicology 84%
  • Industry 79%
  • Safety 50%
  • Drug Development 41%
  33 Scopus citations
• 2015

  Human in vitro ADMET and prediction of human pharmacokinetics and toxicity liabilities at the discovery stage

  Tsaioun, K., Jan 1 2015, In: RSC Drug Discovery Series. 2015-January, 41, p. 110-131 22 p.

  Research output: Contribution to journal › Article › peer-review
• 2013

  Optimizing the use of CROs by academia and small companies

  Lane, R. F., Friedman, L. G., Keith, C., Braithwaite, S. P., Frearson, J. A., Lowe, D. A., Longo, F. M., Refolo, L. M., Watterson, D. M., Tsaioun, K., Shineman, D. W. & Fillit, H. M., Jul 2013, In: Nature Reviews Drug Discovery. 12, 7, p. 487-488 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  5 Scopus citations
• 2012

  ADME (absorption, distribution, metabolism, excretion): The real meaning-avoiding disaster and maintaining efficacy for preclinical candidates

  Tsaioun, K. & Kates, S. A., Jan 1 2012, Translational Stroke Research: From Target Selection to Clinical Trials. Springer New York, p. 617-638 22 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Disasters 100%
  • Drug Development 83%
  • Pharmaceutical Preparations 24%
  • Pharmacokinetics 22%
  • Clinical Trials 19%
  1 Scopus citations
• 2011

  QSAR-based permeability model for drug-like compounds

  Gozalbes, R., Jacewicz, M., Annand, R., Tsaioun, K. & Pineda-Lucena, A., Apr 15 2011, In: Bioorganic and Medicinal Chemistry. 19, 8, p. 2615-2624 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Quantitative Structure-Activity Relationship 100%
  • Permeability 62%
  • Drug 38%
  • Pharmaceutical Preparations 30%
  • Biopharmaceutics 26%
  33 Scopus citations

• Safety of medicine and the use of animals in research

  Archibald, K., Baxter, A. D., Bérubé, K., Bunton, D., Clotworthy, M., Coleman, B., Foster, C. S., Hillier, C., McFarlane, M., Patel, A., Pierscionek, B., Root, J., Thomas, G., Tsaioun, K., Wilkinson, J. M., Wilmut, I. & Wright, K. L., 2011, In: The Lancet. 378, 9802, p. e2

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Scopus citations

• VC firms must change early-stage investment strategies

  Tsaioun, K., Jun 15 2011, In: Genetic Engineering and Biotechnology News. 31, 12

  Research output: Contribution to journal › Comment/debate › peer-review
• 2010

  ADMET for Medicinal Chemists: A Practical Guide

  Tsaioun, K. & Kates, S. A., Nov 29 2010, John Wiley and Sons.

  Research output: Book/Report › Book

  • Drug Discovery 100%
  • Drug 76%
  • Pharmaceutical Chemistry 66%
  • Pharmaceutical Preparations 60%
  • Workflow 53%
  23 Scopus citations

• Preface

  Tsaioun, K. & Kates, S. A., Nov 29 2010, ADMET for Medicinal Chemists: A Practical Guide. John Wiley and Sons, p. XV-XVIII

  Research output: Chapter in Book/Report/Conference proceeding › Foreword/postscript
  1 Scopus citations
• 2009

  ADDME - Avoiding Drug Development Mistakes Early: Central nervous system drug discovery perspective

  Tsaioun, K., Bottlaender, M. & Mabondzo, A., Jun 12 2009, In: BMC neurology. 9, SUPPL. 1, S1.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Central Nervous System Agents 100%
  • Drug Discovery 72%
  • Drug Development 66%
  • History 13%
  • Technology 11%
  48 Scopus citations

• Cardionomics: A new integrative approach for screening cardiotoxicity of drug candidates

  Gwathmey, J. K., Tsaioun, K. & Hajjar, R. J., Jun 1 2009, In: Expert Opinion on Drug Metabolism and Toxicology. 5, 6, p. 647-660 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Preclinical Drug Evaluations 100%
  • Cardiotoxicity 95%
  • Drug 44%
  • Pharmaceutical Preparations 34%
  • Drug Industry 24%
  37 Scopus citations

• De-risking drug discovery with ADDME - Avoiding Drug Development Mistakes Early

  Tsaioun, K. & Jacewicz, M., Sep 2009, In: ATLA Alternatives to Laboratory Animals. 37, SUPPL. 1, p. 47-55 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Drug Discovery 100%
  • Drug Development 92%
  • Pharmacological Metabolism 75%
  • Drug 51%
  • History 24%
  14 Scopus citations
• 2000

  Novel growth factor Gas6, phosphatidylserine and their age-related changes in the rat brain

  Tsaioun, K. I., Denisova, N. A., Obin, M. & Joseph, J., Mar 2000, In: Neuroscience Research Communications. 26, 2, p. 113-122 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Phosphatidylserines 100%
  • Synaptosomes 84%
  • Intercellular Signaling Peptides and Proteins 70%
  • Brain 42%
  • Frontal Lobe 32%
  6 Scopus citations
• 1999

  Vitamin K-dependent proteins in the developing and aging nervous system

  Tsaioun, K. I., Aug 1999, In: Nutrition reviews. 57, 8, p. 231-240 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Vitamin K 100%
  • Nervous System 70%
  • Warfarin syndrome 46%
  • Proteins 31%
  • Brain 30%
  48 Scopus citations
• 1997

  Changes in serum osteocalcin, plasma phylloquinone, and urinary γ- carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects

  Sokoll, L. J., Booth, S. L., O'Brien, M. E., Davidson, K. W., Tsaioun, K. I. & Sadowski, J. A., 1997, In: American Journal of Clinical Nutrition. 65, 3, p. 779-784 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Vitamin K 1 100%
  • Osteocalcin 74%
  • Research Subjects 68%
  • Acids 51%
  • Diet 46%
  125 Scopus citations

• Response of vitamin K status to varied intakes of phylloquinone

  Booth, S. L., O'Brien, M. E., Davidson, K. W., Tsaioun, K. I. & Sadowski, J. A., Dec 1 1997, In: FASEB Journal. 11, 3, p. A191

  Research output: Contribution to journal › Article › peer-review

  • Phylloquinone 100%
  • Vitamin K 1 92%
  • Vitamin K 92%
  • 1-Carboxyglutamic Acid 38%
  • Brassica 32%